Tolerance Bio and ZipCode Bio Forge Strategic Collaboration to Develop Targeted RNA-Based Thymus Therapeutics

Tolerance Bio, a biopharmaceutical company pioneering innovative approaches to extending healthspan by preserving, restoring, and manipulating the functi...

September 09, 2025 | Tuesday | News
Certara Launches Pinnacle 21 Enterprise Plus to Streamline Clinical Data Specifications and Accelerate Regulatory Submissions

Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, announced the availability of Pinnacle 21 Enterprise Plus. The solution enables clinical ...

September 05, 2025 | Friday | News
Biocytogen and Merck Join Forces to Advance Antibody-Conjugated Lipid Nanoparticle Delivery Solutions

-Biocytogen Pharmaceuticals), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative techn...

September 04, 2025 | Thursday | News
Quotient Sciences and CPI Form Joint Venture to Accelerate RNA Drug Development

Quotient Sciences, a leading global drug development and manufacturing accelerator, and UK technology innovation centre, CPI, have signed a memorandum of...

September 03, 2025 | Wednesday | News
Thermo Fisher Finalises $4B Solventum Filtration Deal Expanding Bioprocessing Portfolio and Adjacent Markets

Highly Complementary Technologies Strengthen Thermo Fisher’s Portfolio in Bioprocessing and Adjacent Markets Thermo Fisher Scientific Inc. , the w...

September 03, 2025 | Wednesday | News
Thermo Fisher Expands Strategic Partnership with Sanofi to Boost U.S. Manufacturing Capacity

Expanded Strategic Partnership Enables Additional U.S. Manufacturing Capacity to Serve Increased Demand for Pharma/Biotech Customers Thermo Fisher Scien...

September 03, 2025 | Wednesday | News
Novartis Leqvio Achieves Landmark Results in V-DIFFERENCE Phase IV Study

V-DIFFERENCE is first study to show that Leqvio prioritized after statins helps more patients achieve guideline low-density lipoprotein cholesterol (LD...

September 02, 2025 | Tuesday | News
TREOS Bio Secures $2.1M Bridge Financing to Advance Phase II Trial in Colorectal Cancer

Bridge financing of $2.1 million supports initiation of pivotal Phase II study in 140 patients with microsatellite stable metastatic colorectal cancer, a...

August 28, 2025 | Thursday | News
Cube Biotech’s NativeMP™ Technology Powers First-Ever DEL Screening of Membrane Proteins with X-Chem

Cube Biotech, a pioneer in membrane protein stabilization and purification, and X-Chem, the global leader in DNA-Encoded Library (DEL) technology and dat...

August 22, 2025 | Friday | News
Agilent MMR IHC Panel pharmDx Wins FDA Approval as Companion Diagnostic for Colorectal Cancer

-Agilent Technologies Inc. announced that its MMR IHC Panel pharmDx (Dako Omnis) has received FDA approval as a companion diagnostic (CDx) test for ...

August 21, 2025 | Thursday | News
BioSkryb Genomics Secures Exclusive License for Stanford and CZ Biohub SF Innovation in Single-Cell Methylation and Variant Analysis

The licensed IP enables genome-wide methylation and variant analyses in the same single cells or ultra-low input samples BioSkryb Genomics, a ...

August 21, 2025 | Thursday | News
Trethera Secures $3 Million NIH Grant to Advance TRE-515 for Lupus Treatment

Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune d...

August 20, 2025 | Wednesday | News
CILA Therapeutics Secures NIH Grant to Advance CIL-Key™ Platform for Inhaled RNA Delivery in Lung Diseases

-CILA Therapeutics has been awarded a competitive grant from the National Center for Advancing Translational Sciences (NCATS), part of the National Insti...

August 15, 2025 | Friday | News
Cytiva and Culture Biosciences Partner to Deliver Seamless Scale-Up with Stratyx 250 Bioreactor

  Cytiva has deepened its partnership with Culture Biosciences, introducing the Stratyx 250 process development bioreactor. Speaking to BioPharma Boa...

August 18, 2025 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close